February 23, 2026: New Weight Loss Drug Fails to Outperform Zepbound in Clinical Trial Zepbound was not outperformed in a clinical trial of a competitors new GLP-1 weight loss drug formulation
Someone might need to use one if they: Need a certain dose or strength that is not commercially available Need a different form of medication Are allergic to something like lactose or gluten Need flavored medication for a child Compounded drugs are supposed to always contain FDA-approved ingredients, according to Harvard, but the formulations arent reviewed by the FDA for purity, safety or effectiveness
This medication works by mimicking the action of the naturally occurring GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
But there arent many options for ordering Saxenda directly from Mexican pharmacies and having it shipped to the US
882-P: Eloralintide, a selective, long-acting amylin receptor agonist for obesityphase 1 proof of concept